QID 378388

Date Published: 2023-04-12

QID 378388: Adobe Acrobat and Reader Arbitrary Code Execution Vulnerability (APSB23-24)

Adobe Acrobat and Reader are applications for handling PDF files developed and marketed by Adobe Systems.

Affected Versions:
Adobe Acrobat DC - Continuous - 23.001.20093 and prior Windows and MacOS
Adobe Acrobat Reader DC - Continuous - 23.001.20093 and prior Windows and MacOS
Adobe Acrobat 2020 - Classic 2020 - 20.005.30441 and prior Windows and MacOS
Adobe Acrobat Reader 2020 - Classic 2020 - 20.005.30441 and prior Windows and MacOS

QID Detection Logic:(Authenticated)
This QID checks vulnerable versions of Adobe Acrobat and Reader.

Successful exploitation could lead to arbitrary code execution, privilege escalation, security feature bypass and memory leak.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Medium - 5.4 severity.

Solution

Adobe has released fix to address this issue. Customers are advised to refer to APSB23-24 for updates pertaining to this vulnerability.

Vendor References

APSB23-24 - helpx.adobe.com//security/products/acrobat/apsb23-24.html

CVEs related to QID 378388

CVE-2023-26395 | CVE-2023-26396 | CVE-2023-26397 | CVE-2023-26405 | CVE-2023-26406 | CVE-2023-26407 | CVE-2023-26408 | CVE-2023-26417 | CVE-2023-26418 | CVE-2023-26419 | CVE-2023-26420 | CVE-2023-26421 | CVE-2023-26422 | CVE-2023-26423 | CVE-2023-26424 | CVE-2023-26425 |

Software Advisories

Advisory ID	Software	Component	Link
APSB23-24			helpx.adobe.com//security/products/acrobat/apsb23-24.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].